Correlation Engine 2.0
Clear Search sequence regions


  • Adh5 (1)
  • AKR1A1 (10)
  • aldehyde (4)
  • CBR1 (1)
  • cellular (1)
  • enzymes (1)
  • GSNO (8)
  • GSNOR (7)
  • humans (1)
  • low (3)
  • mammals (1)
  • mice (2)
  • mice knockout (1)
  • minor (1)
  • molecular- weight (3)
  • mutagenesis (1)
  • nad (2)
  • nad (1)
  • nadp (2)
  • nadp (6)
  • nitric oxide (2)
  • protein human (1)
  • reductases (1)
  • signal (1)
  • Sizes of these terms reflect their relevance to your search.

    Oxidative modification of Cys residues by NO results in S-nitrosylation, a ubiquitous post-translational modification and a primary mediator of redox-based cellular signaling. Steady-state levels of S-nitrosylated proteins are largely determined by denitrosylase enzymes that couple NAD(P)H oxidation with reduction of S-nitrosothiols, including protein and low-molecular-weight (LMW) S-nitrosothiols (S-nitroso-GSH (GSNO) and S-nitroso-CoA (SNO-CoA)). SNO-CoA reductases require NADPH, whereas enzymatic reduction of GSNO can involve either NADH or NADPH. Notably, GSNO reductase (GSNOR, Adh5) accounts for most NADH-dependent GSNOR activity, whereas NADPH-dependent GSNOR activity is largely unaccounted for (CBR1 mediates a minor portion). Here, we de novo purified NADPH-coupled GSNOR activity from mammalian tissues and identified aldo-keto reductase family 1 member A1 (AKR1A1), the archetypal mammalian SNO-CoA reductase, as a primary mediator of NADPH-coupled GSNOR activity in these tissues. Kinetic analyses suggested an AKR1A1 substrate preference of SNO-CoA > GSNO. AKR1A1 deletion from murine tissues dramatically lowered NADPH-dependent GSNOR activity. Conversely, GSNOR-deficient mice had increased AKR1A1 activity, revealing potential cross-talk among GSNO-dependent denitrosylases. Molecular modeling and mutagenesis of AKR1A1 identified Arg-312 as a key residue mediating the specific interaction with GSNO; in contrast, substitution of the SNO-CoA-binding residue Lys-127 minimally affected the GSNO-reducing activity of AKR1A1. Together, these findings indicate that AKR1A1 is a multi-LMW-SNO reductase that can distinguish between and metabolize the two major LMW-SNO signaling molecules GSNO and SNO-CoA, allowing for wide-ranging control of protein S-nitrosylation under both physiological and pathological conditions. © 2019 Stomberski et al.

    Citation

    Colin T Stomberski, Puneet Anand, Nicholas M Venetos, Alfred Hausladen, Hua-Lin Zhou, Richard T Premont, Jonathan S Stamler. AKR1A1 is a novel mammalian S-nitroso-glutathione reductase. The Journal of biological chemistry. 2019 Nov 29;294(48):18285-18293

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 31649033

    View Full Text